<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Ai-Assisted-Evidence-Synthesis on Bioecon</title><link>https://en.bioecon.ru/technologies/ai-assisted-evidence-synthesis/</link><description>Recent content in Ai-Assisted-Evidence-Synthesis on Bioecon</description><generator>Hugo</generator><language>en-US</language><lastBuildDate>Tue, 18 Aug 2026 22:19:08 +0700</lastBuildDate><atom:link href="https://en.bioecon.ru/technologies/ai-assisted-evidence-synthesis/index.xml" rel="self" type="application/rss+xml"/><item><title>Health economics and outcomes research (HEOR) services</title><link>https://en.bioecon.ru/technology/heor-b2b-services/</link><pubDate>Sun, 16 Aug 2026 14:21:36 +0000</pubDate><guid>https://en.bioecon.ru/technology/heor-b2b-services/</guid><description>Specialist research organizations that build the economic and clinical-outcomes evidence pharmaceutical and biotech companies need to justify a product&amp;rsquo;s value to payers and health-technology-assessment bodies — modeling cost-effectiveness, synthesizing real-world evidence and preparing HTA dossiers.</description></item></channel></rss>